Atlas Trials

Biofrontera Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biofrontera Inc.

RecordFirmDate
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp (NCT05662202)Biofrontera Inc.2022-12-12
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults (NCT05080764)Biofrontera Inc.2021-12-10
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). (NCT03573401)Biofrontera Inc.2018-09-25

Track Biofrontera Inc. automatically

Every clearance here is in the API, with alerts when new ones post.